|
1
|
Huang F, Qian H, Gao F, Chen J, Zhang G, Liu Y, Chen Y, Lin X, Chen F, Song W, Yang D, Chen W, Jiang C, Liu C, Zheng T, Gong C, Ye P, Zheng X. Effect of Ultrasound-Guided Fascia Iliac Compartment Block with Nalbuphine and Ropivacaine on Preoperative Pain in Older Patients with Hip Fractures: A Multicenter, Triple-Blinded, Randomized, Controlled Trial. Pain Ther 2022; 11:923-935. [PMID: 35674985 PMCID: PMC9314510 DOI: 10.1007/s40122-022-00397-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Accepted: 05/17/2022] [Indexed: 01/11/2023] Open
Abstract
INTRODUCTION Pain management for older patients with hip fractures is challenging. This study aimed to investigate the effect of ultrasound-guided fascia iliac compartment block (UGFICB) using different doses of nalbuphine in combination with ropivacaine on preoperative analgesia in older patients with hip fractures. METHODS In this multicenter randomized controlled trial, 280 elderly patients with hip fracture were randomly allocated into four UGFICB groups (n = 70 in each group): a ropivacaine group (30 mL 0.1% ropivacaine + 0.9% normal saline) and three ropivacaine plus nalbuphine groups (5, 10, and 20 mg nalbuphine, respectively). The primary outcomes were the duration of analgesia at rest and on passive movement. Secondary outcomes included sensory block area, side effects, and vital signs. The doses of rescue analgesia with parecoxib sodium were also analyzed. RESULTS The addition of nalbuphine dose-dependently increased the duration of analgesia at rest and on passive movement (P < 0.05) and expanded the area of sensory block (P < 0.05). Compared with the ropivacaine group, the pain scores at rest and on movement at 6 and 8 h after the block were lower in three ropivacaine plus nalbuphine groups (P < 0.05), without between-group differences at 2, 4, and 12 h. The four groups had comparable side effects (nausea and vomiting) and vital signs (P > 0.05). CONCLUSIONS UGFICB with 5, 10, and 20 mg nalbuphine added to ropivacaine prolonged the analgesia duration, increased sensory block area, reduced pain, and decreased the doses of rescue parecoxib sodium for older patients after hip fracture, without obvious side effects. Among these three doses, nalbuphine 20 mg in combination with ropivacaine provided the longest duration of analgesia and the largest sensory block area. TRIAL REGISTRATION Chinese Clinical Trial Registry (ChiCTR2000029934).
Collapse
Affiliation(s)
- Fengyi Huang
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Haitao Qian
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Fei Gao
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Jianghu Chen
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Guopan Zhang
- Department of Anesthesiology, Quanzhou Orthopedic-Traumatological Hospital, Quanzhou, China
| | - Yonglin Liu
- Department of Anesthesiology, Quanzhou Orthopedic-Traumatological Hospital, Quanzhou, China
| | - Yijia Chen
- Department of Anesthesiology, Longyan People's Hospital, Longyan, Fujian, China
| | - Xinqiang Lin
- Department of Anesthesiology, The Affiliated Hospital of Putian College, Putian, China
| | - Fei Chen
- Department of Anesthesiology, Min Dong Hosptial of Ningde, Ningde, China
| | - Wei Song
- Department of Anesthesiology, Zhengxing Hospital of Zhangzhou, Zhangzhou, China
| | - Daihe Yang
- Department of Anesthesiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China
| | - Wenbin Chen
- Department of Anesthesiology, Ningde Municipal Hospital of Ningde Normal University, Ningde, China
| | - Changcheng Jiang
- Department of Anesthesiology, The First Hospital of Quanzhou, Quanzhou, China
| | - Chuyun Liu
- Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
| | - Ting Zheng
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Cansheng Gong
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Peng Ye
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China
| | - Xiaochun Zheng
- Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, 350001, Fujian, China.
- Fujian Provincial Institute of Emergency Medicine, Fujian Provincial Key Laboratory of Emergency Medicine, Fujian Provincial Key Laboratory of Critical Care Medicine, Joint Laboratory of Fujian's Belt and Road, Fuzhou, China.
| |
Collapse
|